From the Food and Drug Administration.

By B. Schwetz. Journal of the American Medical Association (JAMA), 2002

970 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/14320250bbb5d982d5d25fd2903ad9b43d747976

Citations in the corpus

• mHealth 2.0: Experiences, Possibilities, and Perspectives (2014, unknown): “Each of these layers can change independently and may force the others to follow, and for every new combination, an app update may become necessary [49].”
• Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. (2005, unknown): “Prospective data estimating the incidence of DM are beginning to emerge.(2,3) In the Women’s Interagency HIV Study, 20 (3% or 2.”
• 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008, unknown): “In particular, as noted by the FDA, LMWHs are sufficiently distinct that they should be evaluated individually rather than considered as a class of interchangeable agents.(79) The writing group also advises clinicians against drawing comparisons between the new anticoagulant regimens across trials b”